this post was submitted on 11 Aug 2023
569 points (94.4% liked)
Asklemmy
43968 readers
1205 users here now
A loosely moderated place to ask open-ended questions
Search asklemmy ๐
If your post meets the following criteria, it's welcome here!
- Open-ended question
- Not offensive: at this point, we do not have the bandwidth to moderate overtly political discussions. Assume best intent and be excellent to each other.
- Not regarding using or support for Lemmy: context, see the list of support communities and tools for finding communities below
- Not ad nauseam inducing: please make sure it is a question that would be new to most members
- An actual topic of discussion
Looking for support?
Looking for a community?
- Lemmyverse: community search
- sub.rehab: maps old subreddits to fediverse options, marks official as such
- !lemmy411@lemmy.ca: a community for finding communities
~Icon~ ~by~ ~@Double_A@discuss.tchncs.de~
founded 5 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Developing new drugs costs millions and can lasts decades, especially because of clinical trials. Without IP protection, the company making the effort to find new drugs would go bankrupt (the price of newly found drugs must also pay for other drug research that did not succeed). I don't know how it works in the USA, in France the system is that that the IP protection lasts 10 years after releasing the drug on the market, then other companies can copy it. And during this 10 years period, the price is regulated by the government.
This is why pharma shouldn't be for-profit, it needs to be socialized for the good of everyone.